2007 Holiday Reading List

Here are the books I’ll be toting around this holiday season:

property_rights.jpg Jasper A. Bovenberg. Property Rights in Blood, Genes & Data: Naturally Yours? (Nijhoff Law Specials). Brill Academic Publishers, 2006.
science_salvation.jpg Rebecca Dresser. When Science Offers Salvation: Patient Advocacy and Research Ethics. Oxford UP, 2001.
politics_of_life.jpg Nikols Rose. The Politics of Life Itself: Biomedicine, Power, and Subjectivity in the Twenty-First Century. Princeton University Press, 2006.

2005 Holiday Reading List

Atul Butte at PARC Forum

Among the many perks of life in the Bay Area are the frequent geek events which ensure all stripes of technophiliacs are kept occupied.  Long Now Seminars. Future Salons. Nerd Salons. The Hillside ClubDorkbotPARC Forums.  And on and on.  (not to mention the myriad Web 2.0 scene)

The famed PARC has hosted a seminar series for years — dating back to the late 70s.  I recently attended a talk delivered by Atul Butte of Stanford on genomics and medicine.  Talks like this one are more commonly being archived online, taking advantage of the long tail of the internet.


Atul Butte, Stanford University School of Medicine. "Exploring Genomic Medicine Using Integrative Biology" June 15, 2006 at PARC. audio and video

Also see the PARC Forum archives.

(Unfortunately, not everyone is putting their talks online…not even a transcript?)

Note to Readers of TPG

Graduation, a cross-country move, and a great new job
have kept me from blogging for the past two months.  I’m situated now
and will once again be blogging regularly.  I must say that the incentives to stay
indoors on a computer in this city are noticeably fewer than the last
city, so I may have to take up moblogging.

Transition to Clinical Utility

In an attempt to mirror the movement of genomic technologies from the scientific bench to the medical bedside, the editors of the journal Mayo Clinic Proceedings recently announced that they would be transitioning their series of educational articles on medical genomics to a new format which places a greater emphasis on clinical utility:

No one doubts the monumental impact on human health and disease from both the genome project and the unprecedented advances in biotechnology. At the same time, however, it will be some time before human disease in a given patient is sequentially forecasted, prevented, and treated according to genomic profiles. Similarly, clinicians often ask how the current hype in genomics-genetics relates to their day-to-day clinical practice. It is under this premise that the editorial staff of Mayo Clinic Proceedings is pleased to announce the continuation of the Medical Genomics series in the journal with a new and more practical symposium entitled Genetic Test Indications and Interpretations. The new series is scheduled to start in January 2005 and will have a specific disease-oriented approach that demonstrates the transition of technology to clinical utility.

The former series of articles was entitled “Primer on Medical Genomics.” A description of these articles can be found here.

Burrill, Sciona, and Genaissance

From a business wire:

Burrill & Company announced today their investment in Sciona, Inc. Sciona is the leading company in the field of consumer-oriented genetic diagnostics. Based on the latest scientific research, Sciona has created a genetic diagnostic panel that enables manufacturers to customize personal care and nutrition products based on a person’s genetic makeup. Sciona is currently located in Cambridge, UK, but plans to relocate to New Haven, Connecticut, to be nearer to strategic partner and equity stakeholder, Genaissance, Inc.

No comment yet. Just watching.

Entrepreneurial Adolescence: US Genomics

“But as it became clear that personalized medicine, while a powerful vision, wasn’t going to revolutionize the healthcare system overnight, U.S. Genomics entered a wrenching transitional period. I call it entrepreneurial adolescence, which has the following symptoms: The investors get impatient, the founder is booted, a chief executive with more business experience parachutes in, other executives are shuffled, and the company starts searching for near-term revenue possibilities. All that is happening at U.S. Genomics.”

From this Boston Globe article by Scott Kirsner. The near-term revenue possibilities are no longer high throughput genome sequencing, as they once were.

HIMSS Summer 2004

Genomics made a well-received appearance at the HIMSS summer conference.:

“Genomic Medicine: Data Management for the Future of Healthcare”
Speaker: Philip Chen, MD, PhD
Co-founder of the Cognoscenti Health Institute

No proceedings to point to yet, just a program here or a better one here.

If the proceedings for the recent meeting are posted, I’ll let you know. While you’re waiting, if you haven’t taken a look at the proceedings from the recent annual meeting, George Poste gave a talk of interest (check out the powerpoint):

Session #: 74
Topic: Leadership
Genetics and Computing :The Evolution of Molecular Medicine and e-Health
George Poste, DVM, PhD

Impact of Clinical Genomics Assessed

Gwen Acton “Clinical Genomics: The Impact of Genomic Technology on Clinical Trials and Medical Practice” Cambridge Healthtech Advisors. (136 pages @ ~$20/page so not for the merely curious).

Back from Break

Will start blogging again this week after a little break.

Stockpile of Conference Presentations

Presentations from the recent Bio-IT World and Health-IT World conferences are now online. Lots of good stuff. Don’t miss this page containing the keynote addresses.

Next Page →